Comment
We have read an interesting article in which Said et al 1 assessed the prevalence and clinical relevance of gallbladder sonographic abnormalities in 286 patients with confirmed Primary Sclerosing Cholangitis (PSC). They found that gallbladder disease; especially gallstones, cholecystitis and epithelial dysplasia are common manifestations in PSC; furthermore, it seems that cholecystitis is a marker for extrahepatic involvement; supporting the hypothesis that gallbladder epithelium is affected in the inflammatory process of PSC. In regard to the evidence presented, we consider this article of great clinical importance in addressing the importance of hepatobiliary sonographic follow-up in patients with PSC in order to detect premalignant lesions.
Although the precise prognostic implications of gallbladder abnormalities in PSC remain unknown, it seems to be that the only ones clinically relevant are the presence of gallbladder polyps 2 or metaplasia. 3 Gallbladder polyps have been subject of study since the 19 th century, but only recently recognized as lesions of increased risk for malignancy, specially those greater than 1 cm in diameter, sessile and rapidly growing even in less than 1 cm, in patients with concurrent gallstones and in patients older than 50 years. 4 Buckles et. Al 2 found that 13.7% of the patients with PSC that underwent cholecystectomy had a gallbladder mass, 57% of them being malignant, suggesting that in patients with PSC gallbladder polyps must be considered having a greater probability of malignancy; whereas prevalence in patients without PSC ranges from 4.3 5 to 9.5. 6 Leung et al 7 described 4 cases of patients with PSC with gallbladder polyps, all of them presented with adenocarcinoma regardless of size, even when no other «malignancy markers» were found in any of them.
The abnormalities of the biliary tree epithelium in PSC (metaplasia-dysplasia) extend to the gallbladder epithelium 1, 3 and seems to be a marker for extrahepatic involvement. 1 Therefore, for patients whose sonography demonstrates a gallbladder polyp cholecystectomy is warranted, as 60% of those lesions will be malignant. 2, 4 This evidence raises a question whether or not a dysplastic gallbladder polyp should be considered as a marker to prioritize liver transplantation, since the detection of cholangiocarcinoma (CC) before Orthotopic Liver Transplantation (OLT) worsens the 5-year survival rate from 90% to 33%. 8 To the date, biliary dysplasia, instead of gallbladder polyps is an indication for liver transplantation, 9, 10 but since epithelial alterations of PSC are shared by the gallbladder epithelium, we consider that gallbladder polyps should be considered as premalignant lesions, and therefore should be considered as an equivalent to dysplasia regarding the decision to perform a liver transplantation. Since CC is difficult to diagnose in PSC by the current methods available (brush cytology, endobiliary biopsy, CT or MRI scanning, and serum tumor markers) 11 gallbladder polyps detected by sonography would be a feasible detection method.
In conclusion, gallbladder abnormalities are frequent in patients with PSC and gallbladder polyps and dysplasia should be considered of mayor clinical significance. These abnormalities should warrant a sonographic follow up in this particular population.
